HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.

AbstractRATIONALE & OBJECTIVES:
Lower 25-hydroxyvitamin D concentrations have been associated with risk for kidney function decline, heart failure, and mortality. However, 25-hydroxyvitamin D requires conversion to its active metabolite, calcitriol, for most biological effects. The associations of calcitriol concentrations with clinical events have not been well explored.
STUDY DESIGN:
Case-cohort study.
SETTING & PARTICIPANTS:
Well-functioning community-living older adults aged 70 to 79 years at inception who participated in the Health, Aging, and Body Composition (Health ABC) Study.
PREDICTOR:
Serum calcitriol measured using positive ion electrospray ionization-tandem mass spectrometry.
OUTCOMES:
Major kidney function decline (≥30% decline in estimated glomerular filtration rate from baseline), incident heart failure (HF), and all-cause mortality during 10 years of follow-up.
ANALYTIC APPROACH:
Baseline calcitriol concentrations were measured in a random subcohort of 479 participants and also in cases with major kidney function decline [n=397]) and incident HF (n=207) during 10 years of follow-up. Associations of serum calcitriol concentrations with these end points were evaluated using weighted Cox regression to account for the case-cohort design, while associations with mortality were assessed in the subcohort alone using unweighted Cox regression.
RESULTS:
During 8.6 years of mean follow-up, 212 (44%) subcohort participants died. In fully adjusted models, each 1-standard deviation lower calcitriol concentration was associated with 30% higher risk for major kidney function decline (95% CI, 1.03-1.65; P=0.03). Calcitriol was not significantly associated with incident HF (HR, 1.16; 95% CI, 0.94-1.47) or mortality (HR, 1.01; 95% CI, 0.81-1.26). We observed no significant interactions between calcitriol concentrations and chronic kidney disease status, baseline intact parathyroid or fibroblast factor 23 concentrations.
LIMITATIONS:
Observational study design, calcitriol measurements at a single time point, selective study population of older adults only of white or black race.
CONCLUSIONS:
Lower calcitriol concentrations are independently associated with kidney function decline in community-living older adults. Future studies will be needed to clarify whether these associations reflect lower calcitriol concentrations resulting from abnormal kidney tubule dysfunction or direct mechanisms relating lower calcitriol concentrations to more rapid loss of kidney function.
AuthorsUmut Selamet, Ronit Katz, Charles Ginsberg, Dena E Rifkin, Linda F Fried, Stephen B Kritchevsky, Andrew N Hoofnagle, Kirsten Bibbins-Domingo, David Drew, Tamara Harris, Anne Newman, Orlando M Gutiérrez, Mark J Sarnak, Michael G Shlipak, Joachim H Ix
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 72 Issue 3 Pg. 419-428 (09 2018) ISSN: 1523-6838 [Electronic] United States
PMID29885925 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
CopyrightPublished by Elsevier Inc.
Chemical References
  • Biomarkers
  • Calcitriol
Topics
  • Aged
  • Aging (blood, pathology)
  • Biomarkers (blood)
  • Body Composition (physiology)
  • Calcitriol (blood)
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate (physiology)
  • Health Status
  • Heart Failure (blood, diagnosis, mortality)
  • Humans
  • Independent Living (trends)
  • Kidney (physiology)
  • Longitudinal Studies
  • Male
  • Mortality (trends)
  • Random Allocation
  • Renal Insufficiency, Chronic (blood, diagnosis, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: